Search research articles
Contact Us
Filters
Showing results (261-270 of 342) with videos related to
Page
of 35
Sort By:
Neuro-Oncology
|
August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report
Jack M Su, Lindsay B Kilburn, David B Mansur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Sexually Transmitted Infections
|
October 17, 2025
Field evaluation of a dual treponemal/non-treponemal point-of-care test for syphilis within an HIV pre-exposure prophylaxis programme in Hanoi, Vietnam
Ursula Biba, Hao T M Bui, Linh Tp Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study
Erin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report
Brigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Experimental Hematology
|
December 10, 2023
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
Mona A Alqazzaz, Genna M Luciani, Victoria Vu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome
Brigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Page
of 35
Search research articles
Search
Showing results (261-270 of 342) with videos related to
Sort By:
Page
of 35
Neuro-Oncology
|
August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report
Jack M Su, Lindsay B Kilburn, David B Mansur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Sexually Transmitted Infections
|
October 17, 2025
Field evaluation of a dual treponemal/non-treponemal point-of-care test for syphilis within an HIV pre-exposure prophylaxis programme in Hanoi, Vietnam
Ursula Biba, Hao T M Bui, Linh Tp Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study
Erin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report
Brigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Experimental Hematology
|
December 10, 2023
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
Mona A Alqazzaz, Genna M Luciani, Victoria Vu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome
Brigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Page
of 35